Arkema Grants an Exclusive Technology License to SEQENS to manufacture PEKK
25 Jun 2024 //
PRESS RELEASE
Novartis sells France CGT biz to Seqens
19 Dec 2023 //
BIOPROCESSINTEL
Pierre Luzeau on Seqens U.S. R&D Lab Investment
02 Jun 2023 //
CONTRACT PHARMA
Seqens Group Expands CDMO Offerings to Include CRDO
14 Apr 2023 //
CPHI ONLINE